Skip to content

A Prospective Comparison of Fluoroscopic, Sonographic or Combined Approach for Renal Access in Percutaneous Nephrolithotomy

A Prospective and Randomized Comparison of Fluoroscopic, Sonographic or Combined Approach for Renal Access in Percutaneous Nephrolithotomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02266381
Enrollment
450
Registered
2014-10-17
Start date
2014-07-31
Completion date
2015-07-31
Last updated
2016-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urolithiasis

Keywords

PCNL, MPCNL, guidance, puncture

Brief summary

Purpose: The aim of this present study is to compare the result of fluoroscopy, ultrasonography (US) and US combined with fluoroscopy in the guidance of minimally invasive percutaneous nephrolithotomy (MPCNL). Methods: The investigators will enroll 450 patients who are candidates for MPCNL in our study. By simple random sampling technique, patients will be assigned to three 150-patient groups (group 1, US-guided MPCNL, group 2, fluoroscopy-guided MPCNL and group 3, US combined with fluoroscopy-guided MPCNL). In addition to approaches in guidance of MPCNL, the rest of the procedure is the same in all three groups.The end point of the study is the comparison of outcome of procedure including stone free rate, transfusion rate, operation time, access time, length of stay and complications.

Detailed description

Purpose: Recently, PCNL or MPCNL is widely used as the most popular choice to treat patients with all types of renal stones. Successful puncture to the desired renal calyx is the key step for the operation. Nowadays puncture for renal access can be achieve using not only US guidance but fluoroscopy guidance as well. However, it is clear that there is a lack of randomized controlled data comparing fluoroscopy, US and US combined with fluoroscopy in the guidance of MPCNL. Consequently, we performed this randomized controlled trial to obtain higher grade evidence.The aim of this present study is to compare the result of fluoroscopy, US and US combined with fluoroscopy in the guidance of MPCNL. Methods: We will enroll 450 patients who are candidates for MPCNL in our study. By simple random sampling technique, patients will be assigned to three 150-patient groups (group 1, US-guided MPCNL, group 2, fluoroscopy-guided MPCNL and group 3, US combined with fluoroscopy-guided MPCNL). All the patients will be diagnosed definitely before operations with kidney, ureter, and bladder (KUB), intravenous pyelography (IVP), US and/or CT. All procedures are performed by urologists in our center, with assistance from an endourology fellow. Surgical technique: Under general or epidural anaesthesia, each patient is initially placed in the lithotomy position, and a 5 Fr ureteric catheter is advanced to the kidney and fixed with a 16 Fr Foley catheter. Then the patient is turned to the prone position. Group 1: US-guided MPCNL The puncture is made with an 18-gauge needle using an ultrasound probe. After the desirable calix is reached, a flexible-tip guidewire is introduced. We attempt to manipulate the guidewire down to the ureter. If this is not successful, the second choice is to allow the guidewire to coil in a more distant calix. The length of the needle from skin to the collecting system is measured to ensure that the length of dilator is appropriate. The access tract is dilated from 8 Fr to a maximum 18/20 Fr using fascial dilator. We defined access to the collecting system as gaining entry to the targeted urinary system and desired calix. Lithotripsy is performed using either pneumatic lithotriptor or holmium laser. When multiple nephrostomy tracts are necessary to remove the stones, same technique is employed for each of the tracts. Complete stone clearance is confirmed using US at completion of the procedure. We routinely put a double J ureteral catheter into the ureter which is to be removed about 3-4 weeks later after the operation in the out-patients clinic. At the end of the procedure nephrostomy tubes are placed in both groups. The tubes are removed when the drainage from nephrostomy tubes being grossly clear. Group 2 fluoroscopy-guided MPCNL Patients in group 2 have the standard fluoroscopy-guided renal access before MPCNL. Air or contrast medium is injected through the ureteral catheter, the target calix is identified. For tract dilatation fascial dilators are used under fluoroscopic guidance. Complete stone clearance is confirmed fluoroscopically at completion of the procedure. The rest of the procedure is the same as described for patients in group 1. Group 3 US combined with fluoroscopy-guided MPCNL: Under the guidance of ultrasound, the coaxial needle is placed in the desired calyx. A floppy-tipped guidewire is then passed through the needle into the collecting system. The working channel is then dilated under X-ray. US and X-ray check for residual stone fragments are performed at the end of the procedure. The rest of the procedure is the same as described for patients in group 1. Data collection: Data for the three groups -demographic characteristics, access success, access time, duration of radiation exposure, site of target calix, site of access, Hb decrease, duration of postoperative hospital stay, complications (modified Clavien system), stone clearance (SFR after single procedure and final SFR) and the need for auxiliary treatment - are compared. The primary end point of the study is the comparison of outcome of procedure including stone free rate, transfusion rate, operation time, access time, length of stay and complications.

Interventions

PROCEDUREUS-guided renal access

Patients undergo MPCNL using only US-guided renal access.

PROCEDUREFluoroscopy-guided renal access

Patients undergo MPCNL using only fluoroscopy-guided renal access.

PROCEDUREUS combined with fluoroscopy-guided renal access

Patients undergo MPCNL using US combined with fluoroscopy-guided renal access

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Normal renal function. * American society of Anesthesiology (ASA) score 1 and 2. * Absence of congenital abnormalities. * Kidney stones of diameter \> 2.0cm (including multiple and staghorn stones)

Exclusion criteria

* Patients with congenital anomalies, e.g. ectopic kidney, polycystic, horseshoe, or malrotated kidney. * Patients who underwent transplant or urinary diversion. * Patients with solitary kidney. * Patients will be excluded from the study if they undergoing MPCNL have purulent fluid in the initial puncture.

Design outcomes

Primary

MeasureTime frameDescription
Stone Free Rateone day after MPCNLStone-free status is assessed by kidneys-ureter-bladder (KUB) or/ and noncontrast CT at day 1 after MPCNL. A stone-free state is defined as no residual stones of diameter \>4 mm.

Secondary

MeasureTime frameDescription
Perioperative Complicationsintraoperatively or ≤ 30 days postoperativelyComplication is defined as any adverse event occurred intraoperatively or ≤ 30 days postoperatively. Complications included fever, systemic Inflammatory Response Syndrome, septic shock, extravasations, bleeding necessitating transfusion, and sever bleeding necessitating selective renal artery embolization.
Operation TimeintraoperativelyOperation time is defined as the time from puncture to the placement of the nephrostomy tube.
Change in Hemoglobin Concentrationwithin 24 hours after MPCNLChange in hemoglobin concentration is assessed by comparing the preoperative hemoglobin level with 24-hour postoperative hemoglobin level.

Countries

China

Participant flow

Recruitment details

A prospective and randomized study was performed with patient enrollment from July 2014 to May 2015 in the First Affilated Hospital of Guangzhou Medical University. 450 patients were then randomized into three groups. 12 patients had purulent fluid in the kidney at initial punctures. These 12 patients were excluded from the analysis.

Pre-assignment details

549 consecutive patients were assessed for eligibility, 99 were excluded for not meeting the inclusion criteria.

Participants by arm

ArmCount
US-guided Group
Patients in US-guided group undergo MPCNL using only US-guided renal access.
147
Fluoroscopy-guided Group
Patients in Fluoroscopy-guided group undergo MPCNL using only fluoroscopy-guided renal access.
145
Combined-guided Group
Patients in Combined-guided group undergo MPCNL using US combined with fluoroscopy-guided renal access.
146
Total438

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyPhysician Decision354

Baseline characteristics

CharacteristicUS-guided GroupFluoroscopy-guided GroupCombined-guided GroupTotal
Age, Continuous49.9 years
STANDARD_DEVIATION 10.9
49.6 years
STANDARD_DEVIATION 11.3
48.8 years
STANDARD_DEVIATION 11.3
49.4 years
STANDARD_DEVIATION 11.1
Region of Enrollment
China
147 participants145 participants146 participants438 participants
Sex: Female, Male
Female
61 Participants68 Participants58 Participants187 Participants
Sex: Female, Male
Male
86 Participants77 Participants88 Participants251 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
17 / 14731 / 14520 / 146
serious
Total, serious adverse events
0 / 1470 / 1450 / 146

Outcome results

Primary

Stone Free Rate

Stone-free status is assessed by kidneys-ureter-bladder (KUB) or/ and noncontrast CT at day 1 after MPCNL. A stone-free state is defined as no residual stones of diameter \>4 mm.

Time frame: one day after MPCNL

ArmMeasureValue (NUMBER)
US-guided GroupStone Free Rate81 Participants
Fluoroscopy-guided GroupStone Free Rate91 Participants
Combined-guided GroupStone Free Rate98 Participants
Secondary

Change in Hemoglobin Concentration

Change in hemoglobin concentration is assessed by comparing the preoperative hemoglobin level with 24-hour postoperative hemoglobin level.

Time frame: within 24 hours after MPCNL

ArmMeasureValue (MEAN)Dispersion
US-guided GroupChange in Hemoglobin Concentration12.9 g/LStandard Deviation 16
Fluoroscopy-guided GroupChange in Hemoglobin Concentration14.5 g/LStandard Deviation 10
Combined-guided GroupChange in Hemoglobin Concentration13.1 g/LStandard Deviation 10.8
Secondary

Operation Time

Operation time is defined as the time from puncture to the placement of the nephrostomy tube.

Time frame: intraoperatively

ArmMeasureValue (MEAN)Dispersion
US-guided GroupOperation Time60.6 minStandard Deviation 32.9
Fluoroscopy-guided GroupOperation Time63.6 minStandard Deviation 32.5
Combined-guided GroupOperation Time66.3 minStandard Deviation 34.7
Secondary

Perioperative Complications

Complication is defined as any adverse event occurred intraoperatively or ≤ 30 days postoperatively. Complications included fever, systemic Inflammatory Response Syndrome, septic shock, extravasations, bleeding necessitating transfusion, and sever bleeding necessitating selective renal artery embolization.

Time frame: intraoperatively or ≤ 30 days postoperatively

ArmMeasureValue (NUMBER)
US-guided GroupPerioperative Complications17 Participants
Fluoroscopy-guided GroupPerioperative Complications31 Participants
Combined-guided GroupPerioperative Complications20 Participants

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026